hydrochlorothiazide
UkraineDrugs containing this active substance
-
The drug is intended for the treatment of arterial hypertension (high blood pressure), especially in cases where blood pressure cannot be controlled using only one component (ramipril or hydrochlorothiazide).
Form: tablets
Active substance Dosage ramipril 5 mg hydrochlorothiazide 25 mg ATC: C09BA05
Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is intended for the treatment of arterial hypertension (high blood pressure). It is used in cases where blood pressure cannot be properly controlled using only one component (ramipril or hydrochlorothiazide).
Form: tablets
Active substance Dosage ramipril 2.5 mg hydrochlorothiazide 12.5 mg ATC: C09BA05
Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is intended for adult patients with essential hypertension (high blood pressure) if telmisartan monotherapy does not provide adequate blood pressure control.
Form: tablets
Active substance Dosage telmisartan 40 mg hydrochlorothiazide 12.5 mg ATC: C09DA07
Manufacturer: Micro Labs Limited
-
The drug is indicated for adult patients with essential hypertension (high blood pressure) if telmisartan monotherapy does not provide adequate blood pressure control.
Form: tablets
Active substance Dosage telmisartan 80 mg hydrochlorothiazide 12.5 mg ATC: C09DA07
Manufacturer: Micro Labs Limited
-
The drug is intended for adult patients with essential hypertension (high blood pressure) if telmisartan as a monotherapy does not provide adequate blood pressure control.
Form: tablets
Active substance Dosage telmisartan 80 mg hydrochlorothiazide 25 mg ATC: C09DA07
Manufacturer: Micro Labs Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: Daichi Sankyo Europe GmbH (manufacturing "in bulk", packaging, control and batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: Daichi Sankyo Europe GmbH (manufacturing "in bulk", packaging, control and batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg hydrochlorothiazide 25 mg ATC: C09DX03
Manufacturer: Daichi Sankyo Europe GmbH (manufacturing "in bulk", packaging, control and batch release)
-
The drug is intended for adults with essential hypertension (high blood pressure) if blood pressure reduction is insufficient when using only one component (enalapril).
Form: tablets
Active substance Dosage enalapril 10 mg hydrochlorothiazide 25 mg ATC: C09BA02
Manufacturer: Berlin-Chemie AG (bulk manufacturing, batch control, final packaging, quality control and batch release)
-
The drug is prescribed for adults to treat essential hypertension (high blood pressure) if the use of a single component (candesartan or hydrochlorothiazide) alone does not provide sufficient results.
Form: tablets
Active substance Dosage candesartan cilexetil 32 mg hydrochlorothiazide 25 mg ATC: C09DA06
Manufacturer: Evertoxgen Life Sciences Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults if the use of a single component (candesartan or hydrochlorothiazide) alone is insufficient.
Form: tablets
Active substance Dosage candesartan cilexetil 16 mg hydrochlorothiazide 12.5 mg ATC: C09DA06
Manufacturer: Evertoxgen Life Sciences Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults if blood pressure cannot be controlled using only one component (candesartan or hydrochlorothiazide).
Form: tablets
Active substance Dosage candesartan cilexetil 16 mg hydrochlorothiazide 12.5 mg ATC: C09DA06
Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults if blood pressure cannot be controlled using only one component (candesartan or hydrochlorothiazide).
Form: tablets
Active substance Dosage candesartan cilexetil 32 mg hydrochlorothiazide 12.5 mg ATC: C09DA06
Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.
-
The drug is used for the treatment of arterial hypertension (high blood pressure).
Form: tablets
Active substance Dosage captopril 50 mg hydrochlorothiazide 12.5 mg ATC: C09BA01
Manufacturer: PJSC "Kyivmedpreparat"
-
The drug is prescribed for the treatment of arterial hypertension (high blood pressure).
Form: tablets
Active substance Dosage captopril 50 mg hydrochlorothiazide 12.5 mg ATC: C09BA01
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is used to treat arterial hypertension (high blood pressure).
Form: tablets
Active substance Dosage captopril 50 mg hydrochlorothiazide 25 mg ATC: C09BA01
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom taking a single component (olmesartan medoxomil) alone is insufficient to achieve the required blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH (manufacturing in bulk)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom monotherapy (olmesartan medoxomil) is insufficient to achieve the required blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 25 mg ATC: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH (manufacturing in bulk)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in cases where combination therapy is recommended.
Form: tablets
Active substance Dosage ramipril 5 mg hydrochlorothiazide 25 mg ATC: C09BA05
Manufacturer: PJSC Pharmaceutical Plant EGIS (responsible for full production cycle)
-
The drug is intended for the treatment of essential arterial hypertension (high blood pressure) in adults.
Form: capsules, hard
Active substance Dosage candesartan cilexetil 16 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09DX06
Manufacturer: Adamed Pharma S.A.
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults if blood pressure cannot be controlled using a single component alone (candesartan or hydrochlorothiazide).
Form: tablets
Active substance Dosage candesartan cilexetil 32 mg hydrochlorothiazide 25 mg ATC: C09DA06
Manufacturer: PJSC "Kyivmedpreparat"
-
The drug is intended for the treatment of essential arterial hypertension (high blood pressure) in adults.
Form: capsules, hard
Active substance Dosage candesartan cilexetil 16 mg amlodipine 10 mg hydrochlorothiazide 12.5 mg ATC: C09DX06
Manufacturer: Adamed Pharma S.A.
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults if blood pressure cannot be controlled by using only one component (candesartan or hydrochlorothiazide).
Form: tablets
Active substance Dosage candesartan cilexetil 16 mg hydrochlorothiazide 12.5 mg ATC: C09DA06
Manufacturer: PJSC "Kyivmedpreparat"
-
The drug is used to treat mild to moderate essential arterial hypertension (high blood pressure) if blood pressure cannot be controlled using a single drug alone.
Form: tablets, film-coated
Active substance Dosage valsartan 80 mg hydrochlorothiazide 12.5 mg ATC: C09DA03
Manufacturer: Sandoz S.R.L. (Quality Control)
-
The drug is used to treat mild to moderate essential arterial hypertension (high blood pressure) if it is not controlled by other means.
Form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 12.5 mg ATC: C09DA03
Manufacturer: Sandoz S.R.L. (Quality Control)
-
The drug is used to treat mild to moderate essential arterial hypertension (high blood pressure) in cases where blood pressure cannot be controlled using a single drug alone.
Form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 25 mg ATC: C09DA03
Manufacturer: Sandoz S.R.L. (Quality Control)
-
The drug is used to treat mild to moderate essential arterial hypertension (high blood pressure) if it is not controlled by other treatment methods.
Form: tablets, film-coated
Active substance Dosage valsartan 320 mg hydrochlorothiazide 12.5 mg ATC: C09DA03
Manufacturer: Sandoz S.R.L. (Quality Control)
-
The drug is used to treat mild to moderate essential arterial hypertension (high blood pressure) if blood pressure cannot be controlled using a single drug alone.
Form: tablets, film-coated
Active substance Dosage valsartan 320 mg hydrochlorothiazide 25 mg ATC: C09DA03
Manufacturer: Sandoz S.R.L. (Quality Control)
-
The drug is intended for the treatment of patients with mild to moderate arterial hypertension (high blood pressure) if the patient's condition has already been stabilized with therapy using other individual drugs.
Form: tablets
Active substance Dosage lisinopril 10 mg hydrochlorothiazide 12.5 mg ATC: C09BA03
-
The drug is prescribed for the treatment of mild to moderate arterial hypertension (high blood pressure) if the patient has already been taking other medications at appropriate doses and their condition has stabilized.
Form: tablets
Active substance Dosage lisinopril 20 mg hydrochlorothiazide 12.5 mg ATC: C09BA03
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults if blood pressure cannot be adequately controlled using a single component (irbesartan or hydrochlorothiazide) alone.
Form: tablets, film-coated
Active substance Dosage irbesartan 150 mg hydrochlorothiazide 12.5 mg ATC: C09DA04
Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults if blood pressure cannot be adequately controlled using a single component (irbesartan or hydrochlorothiazide) alone.
Form: tablets, film-coated
Active substance Dosage irbesartan 300 mg hydrochlorothiazide 12.5 mg ATC: C09DA04
Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.
-
The drug is used to treat essential hypertension (high blood pressure) in adults whose blood pressure is not controlled by other medications.
Form: tablets, film-coated
Active substance Dosage amlodipine 5 mg valsartan 160 mg hydrochlorothiazide 12.5 mg ATC: C09DX01
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults whose blood pressure is not controlled by other drug combinations.
Form: tablets, film-coated
Active substance Dosage amlodipine 10 mg valsartan 160 mg hydrochlorothiazide 12.5 mg ATC: C09DX01
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults whose blood pressure is not controlled by other drug combinations.
Form: tablets, film-coated
Active substance Dosage amlodipine 10 mg valsartan 160 mg hydrochlorothiazide 25 mg ATC: C09DX01
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults whose blood pressure is not controlled by a combination of other drugs.
Form: tablets, film-coated
Active substance Dosage amlodipine 5 mg valsartan 160 mg hydrochlorothiazide 12.5 mg ATC: C09DX01
Manufacturer: JSC "Kyiv Vitamin Plant"
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults whose blood pressure is not controlled by a combination of other drugs.
Form: tablets, film-coated
Active substance Dosage amlodipine 10 mg valsartan 160 mg hydrochlorothiazide 12.5 mg ATC: C09DX01
Manufacturer: JSC "Kyiv Vitamin Plant"
-
The drug is intended for the treatment of mild to moderate essential arterial hypertension (high blood pressure) in cases where blood pressure cannot be controlled with monotherapy.
Form: tablets, film-coated
Active substance Dosage valsartan 80 mg hydrochlorothiazide 12.5 mg ATC: C09DA03
Manufacturer: Farmak JSC
-
The drug is used to treat mild to moderate essential arterial hypertension (high blood pressure) in cases where blood pressure cannot be controlled using a single drug alone.
Form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 12.5 mg ATC: C09DA03
Manufacturer: Farmak JSC
-
The drug is intended for the treatment of mild to moderate essential arterial hypertension (high blood pressure) in cases where blood pressure cannot be controlled using a single drug alone.
Form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 25 mg ATC: C09DA03
Manufacturer: Farmak JSC
-
The drug is intended for the treatment of mild to moderate essential arterial hypertension (high blood pressure) in cases where blood pressure cannot be controlled using a single drug alone.
Form: tablets, film-coated
Active substance Dosage valsartan 320 mg hydrochlorothiazide 12.5 mg ATC: C09DA03
Manufacturer: Farmak JSC
-
The drug is intended for the treatment of mild to moderate essential arterial hypertension (high blood pressure) in cases where blood pressure cannot be controlled using a single drug alone.
Form: tablets, film-coated
Active substance Dosage valsartan 320 mg hydrochlorothiazide 25 mg ATC: C09DA03
Manufacturer: Farmak JSC
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults whose blood pressure is adequately controlled by a combination of three separate drugs or two drugs (one of which is a combination).
Form: tablets, film-coated
Active substance Dosage valsartan 160 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09DX01
Manufacturer: Farmak JSC
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults whose blood pressure is adequately controlled by a combination of three separate drugs or two drugs (one of which is a combination).
Form: tablets, film-coated
Active substance Dosage valsartan 160 mg amlodipine 10 mg hydrochlorothiazide 12.5 mg ATC: C09DX01
Manufacturer: Farmak JSC
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults whose blood pressure is not controlled by a combination of individual drugs or dual combinations.
Form: tablets, film-coated
Active substance Dosage amlodipine 5 mg valsartan 160 mg hydrochlorothiazide 12.5 mg ATC: C09DX01
Manufacturer: ALKALOID AD Skopje (secondary packaging (alternative manufacturer), batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults whose blood pressure is not controlled by other combinations of drugs.
Form: tablets, film-coated
Active substance Dosage amlodipine 5 mg valsartan 160 mg hydrochlorothiazide 25 mg ATC: C09DX01
Manufacturer: ALKALOID AD Skopje (secondary packaging (alternative manufacturer), batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults.
Form: tablets, film-coated
Active substance Dosage amlodipine 10 mg valsartan 160 mg hydrochlorothiazide 25 mg ATC: C09DX01
Manufacturer: ALKALOID AD Skopje (secondary packaging (alternative manufacturer), batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adult patients.
Form: tablets, film-coated
Active substance Dosage amlodipine 10 mg valsartan 320 mg hydrochlorothiazide 25 mg ATC: C09DX01
Manufacturer: ALKALOID AD Skopje (secondary packaging (alternative manufacturer), batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults whose blood pressure is not controlled by a combination of individual drugs or two-component combinations.
Form: tablets, film-coated
Active substance Dosage amlodipine 10 mg valsartan 160 mg hydrochlorothiazide 12.5 mg ATC: C09DX01
Manufacturer: ALKALOID AD Skopje (secondary packaging (alternative manufacturer), batch release)
-
The drug is intended for the treatment of mild to moderate arterial hypertension (high blood pressure) in patients whose condition has been stabilized using the individual components of the drug.
Form: tablets
Active substance Dosage enalapril 10 mg hydrochlorothiazide 25 mg ATC: C09BA02
Manufacturer: KRKA, d.d., Novo mesto